Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression

Details for Australian Patent Application No. 2005305882 (hide)

Owner N.V. Organon

Inventors Ferrier, Nicol; Gartside, Sasha E.; Young, Allan H.; Grassie, Morag; Ingram, Collin D.

Agent Spruson & Ferguson

Pub. Number AU-B-2005305882

PCT Pub. Number WO2006/053884

Priority 04257199.2 19.11.04 EP

Filing date 16 November 2005

Wipo publication date 26 May 2006

Acceptance publication date 14 July 2011

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

Event Publications

31 May 2007 PCT application entered the National Phase

  PCT publication WO2006/053884 Priority application(s): WO2006/053884

14 July 2011 Application Accepted

  Published as AU-B-2005305882

10 November 2011 Standard Patent Sealed

22 December 2011 Alteration of Name

  The name of the patentee has been altered to MSD Oss B.V.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005305902-Support structure for elevated floor assembly

2005305880-Benzothiazole formulations and use thereof